There is no product in the shopping cart, buy it!
| Description | GlycoFlux™ AAV1-PDE3A Viral Particle sustains PDE3A expression to modulate cAMP/cGMP signaling dynamics underlying platelet aggregation and vascular smooth muscle tone, facilitating pharmacology around heart failure targets; this product preferentially transduces smooth muscle and liver for prolonged cyclic-nucleotide mapping and is provided as a replication-incompetent reagent for research use only. |
| Product Type | Recombinant AAV1 |
| Target | PDE3A |
| Species | Human |
| Promotor | CMV, CAG, TRE, or other promoters |
| Tissue Tropism | Smooth muscle, Central Nervous System (CNS), Retina, Pancreas, Inner Ear, Heart, Liver |
| Packaging System | AAV Triple-Plasmid Transfection System |
| Packaging Cell | HEK293T |
| Application | This AAV1 viral particle is primarily used for overexpressing target genes in muscle tissues (smooth muscle, heart) and the central nervous system (CNS) / sensory organs (retina, inner ear). It is an ideal tool for research and pre-clinical studies focused on myopathies, cardiac disorders, and certain neurological or sensory genetic diseases. |
| Shipping | Shipped on dry ice, with temperature maintained at ≤ -80°C. |
| Storage | Store at -80°C to preserve viral titer and stability. |
| Handling Notes | Store this product at -80°C and minimize freeze-thaw cycles to preserve viral titer. For safety, handle in a certified biological safety cabinet and wear appropriate PPE (lab coat, gloves, and eye protection). |
| Product Disclaimer | This product is intended for research use only and is not approved for diagnostic procedures or clinical applications. Users are solely responsible for implementing appropriate safety practices and complying with all applicable laws, regulations, and institutional policies. While Creative Biolabs is committed to rigorous quality control, no guarantee is made regarding performance in any particular assay or application. |
| Titer Assay | qPCR/TCID50 |
| Mycoplasma Test | No mycoplasma contamination was detected. |
| Sterility | Sterility testing verified the absence of microbial contamination. |
| Transduction Evaluation | Upon request, Creative Biolabs performs in vitro or in vivo transduction assays to assess AAV delivery to target cells and to quantify transgene expression and function. |
| Insert Identity Confirmation | All AAV preparations from Creative Biolabs are verified for vector-genome identity by PCR. In this assay, target cells are transduced with serial dilutions of the AAV preparation, harvested after a short incubation, and genomic DNA is isolated; a defined region of the packaged transgene is then PCR-amplified to confirm the expected sequence. |
| Full Name | Phosphodiesterase 3A |
| Alternative Name | HTNB; CGI-PDE; CGI-PDE A; CGI-PDE-A |
| Location | 12p12.2 |
| Gene ID | 5139 |
| Summary | This gene encodes a member of the cGMP-inhibited cyclic nucleotide phosphodiesterase (cGI-PDE) family. cGI-PDE enzymes hydrolyze both cAMP and cGMP, and play critical roles in many cellular processes by regulating the amplitude and duration of intracellular cyclic nucleotide signals. The encoded protein mediates platelet aggregation and also plays important roles in cardiovascular function by regulating vascular smooth muscle contraction and relaxation. Inhibitors of the encoded protein may be effective in treating congestive heart failure. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. |